Security key
690469101
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 38,559,195
- Total 13F value
- $71,717,529
- Share change
- +1,372,466
- SEC-reported price per share
- $1.86
- Number of holders
- 58
- Value change
- +$2,582,813
- Number of buys
- 19
- Number of sells
- 26
- Shares outstanding
- 187,450,569
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
58
Top holders
10
OVID full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Ovid Therapeutics Inc. SEC filings
Ovid Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 690469101
Recent filing periods:
Ownership snapshot
Top reported holders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F
3/4/5
Highest disclosed value: $12,606,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL has the largest disclosed position value at $12.61M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Disclosed position value
Top 5
BVF INC/IL
$12.61M
EcoR1 Capital, LLC
$11.26M
Rubric Capital Management LP
$8.31M
VANGUARD GROUP INC
$4.75M
Artal Group S.A.
$4.6M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$12,606,000
6,851,051 shares
|
— | 30 Sep 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
—
denominator unverified
|
$11,256,000
6,117,400 shares
|
— | 30 Sep 2022 |
| Rubric Capital Management LP |
13F
Company
|
—
denominator unverified
|
$8,310,000
4,516,300 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,748,000
2,580,590 shares
|
— | 30 Sep 2022 |
| Artal Group S.A. |
13F
Company
|
—
denominator unverified
|
$4,600,000
2,500,000 shares
|
— | 30 Sep 2022 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$3,363,000
1,829,352 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
58
Shares
38,559,195
Rows available
58
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
55
Q4 2022 holders
58
Holder diff
3
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend